Breathe Well Live Well
 eYugoslavia.com |
New ATS Guideline Recommends Measuring Airway Inflammation in Asthma …
MarketWatch (press release) SOLNA, Sweden, Sep 02, 2011 (BUSINESS WIRE) — Aerocrine AB (sto:AERO) today announced that the American Thoracic Society has released an official clinical practice guideline that provides strong recommendations to measure FENO in patients with asthma. … ATS publishes clinical practice guidelines on interpretation of FENO levels |
View full post on asthma – Google News
|
UnitedHealthcare and Sesame Workshop Launch Bilingual Childhood Asthma …
MarketWatch (press release) "A is for Asthma" and "Lead Away!" programs feature tips and activities from Sesame Street characters Elmo, Grover, Bert and Zoe to help millions of kids stay healthy MINNETONKA, Minn., Aug 18, 2011 (BUSINESS WIRE) — UnitedHealthcare and Sesame … |
View full post on asthma – Google News
|
Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal …
MarketWatch (press release) In addition, Array initiated new clinical trials for two proprietary anti-inflammatory drugs: ARRY-797 for pain and ARRY-502 for asthma. ARRY-797 is being tested in a 150-patient Phase 2 chronic pain trial in osteoarthritis (OA) patients with top-line … |
View full post on asthma – Google News
|
'Build Smart, Breathe Easier' Program Dedicates First House with Asthma …
MarketWatch (press release) WHITEHOUSE STATION, NJ, July 26, 2011 /PRNewswire via COMTEX/ — The first Habitat for Humanity house built as part of the Build Smart, Breathe Easier national asthma education program will be dedicated in partnership with the Dunmore family in Detroit … |
View full post on asthma – Google News
|
Emerging Asthma Agents That Offer the Convenience of Once-Daily Dosing Will …
MarketWatch (press release) The findings from the Pharmacor topic entitled Asthma reveal that Relovair will emerge as the market leader among once-daily LABA/ICS combinations as GlaxoSmithKline wages an aggressive campaign to switch patients off of Advair/Seretide/Adoair prior to … |
View full post on asthma – Google News
|
Knowing your allergies can save your life
MarketWatch Allergic diseases, such as asthma, affect as many as 50 million Americans, according to the American Academy of Allergy, Asthma and Immunology (AAAAI). … |
View full post on asthma – Google News
|
Dr. Reddy's launches generic asthma drug in US
MarketWatch BY) Saturday said it has launched the generic asthma drug zafirlukast in the US market after receiving a favorable court decision. Zafirlukast is a generic … Dr Reddy's launches anti-asthma tablets in US Dr Reddy's gets FDA nod to launch anti-asthma tablets in US Dr Reddys Laboratories announces the launch of Zafirlukast tablets |
View full post on asthma – Google News
|
MediciNova Reports Third Quarter 2010 Results
MarketWatch (press release) The presentations are related to MediciNova's development of MN-221 for potential utility in acute exacerbations of asthma or chronic obstructive pulmonary … |
View full post on asthma – Google News
|
Teva Highlights QNAZE(TM) HFA Phase III Data at the 2010 Annual Meeting of the …
MarketWatch (press release) The results, presented at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Phoenix, Ariz., showed that the … |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
MarketWatch (press release) Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates, … KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … |
View full post on asthma – Google News